Page last updated: 2024-09-03

reboxetine and Agoraphobia

reboxetine has been researched along with Agoraphobia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dannon, PN; Grunhaus, L; Iancu, I	1
Benedetti, A; Cassano, G; Mastalli, L; Nardi, A; Perugi, G; Savino, M; Versiani, M	1

Trials

2 trial(s) available for reboxetine and Agoraphobia

Article	Year
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study. Human psychopharmacology, 2002, Volume: 17, Issue:7 Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Antidepressive Agents; Drug Resistance; Female; Humans; Male; Morpholines; Panic Disorder; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors	2002
Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Comorbidity; Constipation; Double-Blind Method; Female; Humans; Male; Morpholines; Norepinephrine; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Xerostomia	2002

Article

Year

The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study.

Human psychopharmacology, 2002, Volume: 17, Issue:7

Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Antidepressive Agents; Drug Resistance; Female; Humans; Male; Morpholines; Panic Disorder; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors

2002

Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.

The Journal of clinical psychiatry, 2002, Volume: 63, Issue:1

Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Comorbidity; Constipation; Double-Blind Method; Female; Humans; Male; Morpholines; Norepinephrine; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Xerostomia

2002